Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

Share Price is delayed by 15 minutes
Get Live Data
6.55    0.00 (0.00%)
Bid:
6.20
Ask:
6.90
Spread: 0.70 (11.29%)
Market Cap: £70.42m
ANIC Live PriceLast checked at - London Stock Exchange

Intraday Agronomics Share Chart

Net Asset Value(s)

30 Jul 2015 07:01

RNS Number : 4818U
Port Erin Biopharma Investments Ltd
30 July 2015
 

7.00am 30 July 2015

Port Erin Biopharma Investments Limited

(the "Company")

 

Net Asset Value calculation to 30 June 2015

 

Jim Mellon, Chairman, commented: -

"The Net Asset Value ("NAV") calculation for the Company as at closing on 30 June 2015 was 11.47 pence per share, including un-invested cash of £255,564. The portfolio is valued under IFRS at bid price.

Net Assets stand at £2.7 million including Investments of £2.5 million. This quarter's NAV represents a decrease of 6.9% from the previous valuation of 12.32 pence per share, which included un-invested cash of £405,665. On this basis, no additional management fee is due to Shellbay Investments Limited.

The reported NAV to 30 June 2015 suffered due to some adverse foreign exchange fluctuations in our holdings on translation to the sterling reporting currency. The underlying value of our investments in unaffected by these accounting movements and has no cash impact. The portfolio continues to demonstrate strong fundamentals, including Plethora Solutions Holdings plc which enjoyed an uplift of 21% over the quarter."

 

 

 

Unaudited to 30 June 2015 £

Fixed Assets

 

 

 

Investments

2,454,953

Current Assets

 

 

 

Sundry Debtors

11,846

 

Uninvested cash

255,564

Current Liabilities

 

 

 

Creditors: amounts due

(61,600)

 

 

2,660,763

Capital and Reserves

 

 

 

Share Capital

23

 

Share Premium

1,890,142

 

Reserves

770,598

 

 

2,660,763

 

 

 

Shares in Issue

 

23,195,558

 

 

 

Net Asset Value per share

 

11.47 pence

 

 

 

Portfolio Details

 

Investments as at 30 June 2015

Value

% of Total Portfolio

 

 

 

 

 

Magna Biopharma Income Fund

£1,238,846

50.5%

 

Plethora Solutions Holdings

£310,000

12.6%

 

Summit Corporation

£408,150

16.6%

 

Other quoted holdings

£188,665

7.7%

 

Other unquoted holdings

£309,292

12.6%

 

Total

£2,454,953

100.0%

 

 

 

For further information, please contact:

 

Port Erin Biopharma

Investments Limited

Beaumont Cornish Limited

Peterhouse Capital Limited

The Company

Nomad

Broker

 

 

 

Denham Eke

(+44) (0) 1624 639396

Roland Cornish

(+44) (0) 207 628 3396

Lucy Williams

(+44) (0) 207 469 0936

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVFMGZNKLVGKZM
Date   Source Headline
4th Jun 20265:59 pmRNS-RAgronomics portfolio company HydGene Update
4th Jun 20265:58 pmRNS-RAgronomics portfolio company Bond Pet Foods Update
18th May 20267:00 amRNSNet Asset Value calculation as at 31 March 2026
12th May 20267:00 amRNSAgronomics leads US$5m investment in SuperMeat
7th May 20264:04 pmRNSMeatly completes £10.4 million Series A funding
15th Apr 20261:29 pmRNS-RClean Food Group Update
14th Apr 20267:00 amRNS-RTropic’s product receives regulatory approval
1st Apr 202612:50 pmRNS-RAll G secures FDA "no questions" letter
25th Mar 20263:45 pmRNS-RClean Food Group Update
19th Mar 202612:30 pmRNS-RTropic Biosciences Update
12th Mar 20265:31 pmRNSDirector's Dealing
4th Mar 20267:00 amRNSDirector’s Dealing
25th Feb 20265:04 pmRNSDirector’s Dealing
20th Feb 20265:15 pmRNSDirector’s Dealing
19th Feb 20262:10 pmRNSDirector’s Dealing
17th Feb 20267:00 amRNSHalf-year Financial Report
13th Feb 20264:31 pmRNSResult of AGM
9th Feb 20267:00 amRNSNet Asset Value calculation as at 31 December 2025
15th Jan 20267:00 amRNSAgronomics invests A$3m in All G & Issue of Equity
30th Dec 20258:00 amRNSFinal Results and Notice of AGM
30th Dec 20258:00 amRNSFinal Results and Notice of AGM
30th Dec 20257:00 amRNSFurther equity investment in BlueNalu
30th Dec 20257:00 amRNSFurther equity investment in BlueNalu
19th Dec 20259:30 amRNSLiberation Bioindustries Series A1 equity round
19th Dec 20259:30 amRNSDissolution of Meatable
19th Dec 20259:30 amRNSDissolution of Meatable
19th Dec 20259:30 amRNSLiberation Bioindustries Series A1 equity round
21st Nov 20258:00 amRNSAgronomics invests US$ 2 million in SuperMeat
13th Nov 20257:00 amRNSNet Asset Value as at 30 September 2025
10th Nov 20257:00 amRNS-REVERY raise US$ 55 million in fresh capital
21st Oct 20257:00 amRNS-RGeltor, Inc Update
30th Sep 20257:00 amRNS-RClean Food Group Update
23rd Sep 20257:00 amRNS-ROnego Bio Update
12th Sep 20258:00 amRNS-RClean Food Group Update
22nd Aug 20258:19 amRNS-RMeatable acquires Meat Technology platform
24th Jul 20257:00 amRNS-RSolar Foods Update
18th Jul 202511:00 amRNSNet Asset Value calculation as at 30 June 2025
11th Jun 20257:00 amRNS-RAgronomics Q2 2025 Newsletter
28th May 20252:55 pmRNS-RMeatly reduces bioreactor and medium costs
12th May 20257:00 amRNSNet Asset Value calculation as at 31 March 2025
8th May 20257:00 amRNS-RLiberation Labs Announce Manufacturing Partnership
6th May 20257:00 amRNS-RMeatable and TruMeat Forge Alliance
30th Apr 20257:00 amRNS-RBlueNalu Expands Partnership with Nomad Foods
15th Apr 20259:00 amRNS-RLiberation Labs secures strategic partnership
18th Mar 20257:00 amRNSExercise of Shellbay options
14th Mar 20258:15 amRNSUnaudited Interim Results
4th Mar 20258:00 amRNS-RSolar Foods Secures €10 million Grant
7th Feb 20253:33 pmRNSResult of AGM
7th Feb 20257:00 amRNS-RMeatly launches first cultivated meat dog treat
4th Feb 20254:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.